Lista de obras -

Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile.

artículo científico publicado en 2016

Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia-ischemia in newborn pigs

artículo científico publicado en 2011

Cannabidiol reduces lung injury induced by hypoxic-ischemic brain damage in newborn piglets.

artículo científico publicado en 2017

Cannabinoid CB1 receptors are expressed by parietal cells of the human gastric mucosa

artículo científico publicado en 2008

Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington's disease.

artículo científico publicado en 2009

Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer's disease

artículo científico publicado en 2018

Cannabinoids: novel medicines for the treatment of Huntington's disease.

artículo científico publicado en 2012

Colocalization of CB1 receptors with L1 and GAP-43 in forebrain white matter regions during fetal rat brain development: evidence for a role of these receptors in axonal growth and guidance

scientific article published on 29 February 2008

Corrigendum to "Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile" [Pharmacol. Res. 110 (August 2016) (2016) 205-215].

artículo científico publicado en 2017

Effects of Cannabidiol and Hypothermia on Short-Term Brain Damage in New-Born Piglets after Acute Hypoxia-Ischemia.

artículo científico publicado en 2016

Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies.

artículo científico publicado en 2015

Hypoxic-ischemic brain damage induces distant inflammatory lung injury in newborn piglets

artículo científico publicado en 2015

Identification of Novel GPR55 Modulators Using Cell-Impedance-Based Label-Free Technology.

artículo científico publicado en 2016

Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.

artículo científico publicado en 2010

Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity.

artículo científico publicado en 2009

Neuronal and non-neuronal bradykinin receptors are involved in the contraction and/or relaxation to the pig bladder neck smooth muscle.

artículo científico publicado en 2013

Neuroprotective Effects of Cannabidiol in Hypoxic Ischemic Insult. The Therapeutic Window in Newborn Mice.

artículo científico publicado en 2016

Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease.

artículo científico publicado en 2011

New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking

artículo científico publicado en 2017

Proliferation of osteoblast precursor cells on the surface of TiO<sub>2</sub> nanowires anodically grown on a β-type biomedical titanium alloy

artículo científico publicado en 2022

Role of interleukin 1-beta in the inflammatory response in a fatty acid amide hydrolase-knockout mouse model of Alzheimer's disease

scientific article published on 06 September 2018

Role of the endocannabinoid system in Alzheimer's disease: new perspectives.

artículo científico publicado en 2004

Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling.

artículo científico publicado en 2014

The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages

artículo científico publicado en 2009

The cannabinoid agonist WIN55212 reduces brain damage in an in vivo model of hypoxic-ischemic encephalopathy in newborn rats.

artículo científico publicado en 2007

The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways

artículo científico publicado en 2016

The endocannabinoid system in Huntington's disease.

artículo científico publicado en 2008

The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG.

scientific article published on 17 October 2013

Tricyclic pyrazoles. Part 8. Synthesis, biological evaluation and modelling of tricyclic pyrazole carboxamides as potential CB2 receptor ligands with antagonist/inverse agonist properties

artículo científico publicado en 2016

aEEG and neurologic exam findings correlate with hypoxic-ischemic brain damage severity in a piglet survival model

scientific article published on 16 January 2019

Lista de obras de

Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile.

Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia-ischemia in newborn pigs

Cannabidiol reduces lung injury induced by hypoxic-ischemic brain damage in newborn piglets.

Cannabinoid CB1 receptors are expressed by parietal cells of the human gastric mucosa

Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington's disease.

Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer's disease

Cannabinoids: novel medicines for the treatment of Huntington's disease.

Colocalization of CB1 receptors with L1 and GAP-43 in forebrain white matter regions during fetal rat brain development: evidence for a role of these receptors in axonal growth and guidance

Corrigendum to "Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile" [Pharmacol. Res. 110 (August 2016) (2016) 205-215].

Effects of Cannabidiol and Hypothermia on Short-Term Brain Damage in New-Born Piglets after Acute Hypoxia-Ischemia.

Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies.

Hypoxic-ischemic brain damage induces distant inflammatory lung injury in newborn piglets

Identification of Novel GPR55 Modulators Using Cell-Impedance-Based Label-Free Technology.

Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.

Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity.

Neuronal and non-neuronal bradykinin receptors are involved in the contraction and/or relaxation to the pig bladder neck smooth muscle.

Neuroprotective Effects of Cannabidiol in Hypoxic Ischemic Insult. The Therapeutic Window in Newborn Mice.

Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease.

New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data and molecular docking

Proliferation of osteoblast precursor cells on the surface of TiO<sub>2</sub> nanowires anodically grown on a β-type biomedical titanium alloy

Role of interleukin 1-beta in the inflammatory response in a fatty acid amide hydrolase-knockout mouse model of Alzheimer's disease

Role of the endocannabinoid system in Alzheimer's disease: new perspectives.

Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling.

The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages

The cannabinoid agonist WIN55212 reduces brain damage in an in vivo model of hypoxic-ischemic encephalopathy in newborn rats.

The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways

The endocannabinoid system in Huntington's disease.

The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG.

Tricyclic pyrazoles. Part 8. Synthesis, biological evaluation and modelling of tricyclic pyrazole carboxamides as potential CB2 receptor ligands with antagonist/inverse agonist properties

aEEG and neurologic exam findings correlate with hypoxic-ischemic brain damage severity in a piglet survival model